Immunology
-
Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice
This article has 24 authors:Reviewed by ScreenIT
-
Favourable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases
This article has 30 authors:Reviewed by ScreenIT
-
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
This article has 46 authors:Reviewed by ScreenIT
-
Antibody conversion rates to SARS-CoV-2 in saliva from children attending summer schools in Barcelona, Spain
This article has 35 authors:Reviewed by ScreenIT
-
SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies
This article has 21 authors:Reviewed by ScreenIT
-
In silico analysis of mutant epitopes in new SARS-CoV-2 lineages suggest global enhanced CD8+ T cell reactivity and also signs of immune response escape
This article has 5 authors:Reviewed by ScreenIT
-
Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection
This article has 44 authors:Reviewed by ScreenIT
-
SARS-CoV-2 vaccination induces neutralizing antibodies against pandemic and pre-emergent SARS-related coronaviruses in monkeys
This article has 43 authors:Reviewed by ScreenIT
-
Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
This article has 6 authors:Reviewed by ScreenIT
-
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
This article has 69 authors:Reviewed by ScreenIT